[Implant surgery in partially edentulous patients with alveolar bone deficiency]. / Khirurgicheskoe lechenie patsientov s ispol'zovaniem implantatov pri chastichnom otsutstvii zubov v usloviiakh defitsita kostnoi tkani.

The article presents the analysis of possible options of dental implant surgical treatment of partially edentulous patients with insufficient alveolar bone volume in the period from 2008 to 2017 (n=1004). Highlighted are three main options for surgical treatment: a staged approach, including alveolar ridge augmentation, subsequent dental implantation (n=562); dental implantation with simultaneous alveolar ridge augmentation (n=362); using of 'narrow/short' dental implants (n=80). The data on the frequency of intra - and postoperative complications before prosthetics are given. Over the past period, there has been a declining tendency in the number of staged procedures with an increase in the number of simultaneous operations installations of 'narrow/short' implants.

[PCR rationale for use of oral cephalosporins by oral surgery procedures].

The article presents the experience of PCR detection of DNA of pathogenic germs inducing odontogenic inflammation. Pus samples of 48 patients aged 18 to 68 years undergoing oral surgery because of apical periodontal lesions and pericoronitis. The results showed microorganisms associations revealed by PCR are sensitive to III generation cephalosporins. Effective oral regimen included 400 mg Ceftibuten once daily. The PCR results thus served as a rationale for use of oral cephalosporins by oral surgery procedures proved by clinical and immunological data in postoperative period.

[Preventive antibacterial treatment in oral bone augmentation procedures].

The paper contains clinical and microbiological base for the use of Ceftibuten for prevention of inflammatory complications after bone augmentation and dental implant placement.

[The clinico-microbiological evaluation of the efficacy of using new drug forms of chlorhexidine--Corsodyl and Eludril--for the prevention of infectious complications in operations for endosseous implantation]. / Kliniko-mikrobiologicheskaia otsenka éffektivnosti primeneniia novykh lekarstvennykh form khlorgeksidina--korsodil i eliudril--dlia profilaktiki infektsionnykh oslozhnenii operatsii vnutrikostnoi implantatsii.

Prevention of infectious inflammatory complications of intraosseous implantation is a pressing problem. Chlorohexidine dosage forms Corsodyl and Eludril were used for this purpose. In the control group, furacillin was used. Microbiological studies showed that instillations of Corsodyl and Eludril solutions during the postoperative period did not modify normal oral microflora and led to disappearance of the most aggressive anaerobic bacteria in 1-3 days. These drugs are more effective that Listerine, and they are recommended for prevention of infectious inflammatory complications after intraosseous implantation.